Description

Market Introduction: Sterile Injectable Contract Manufacturing Market

 

Sterile injectable drugs are liquid dosage forms administered by parenteral route. These drugs directly enter into the circulation system and show quicker therapeutic action. Many pharmaceutical companies are outsourcing manufacturing due to lack of manufacturing capacities or to reduce the cost of manufacturing process. Contract manufacturers provide a wide range of services such as process optimization, analytical characterization, and cGMP among others.

 

Market Dynamics: Sterile Injectable Contract Manufacturing Market

Increase in the prevalence of chronic diseases such as cancer, diabetes, and immunological disorders, development of newer vaccines, patent expiries of blockbuster drugs, and increase in the focus on reformulation of existing products are anticipated to fuel the sterile injectable contract manufacturing market. Moreover, growing demand for sterile injectable products and dearth of captive sterile injectable manufacturing facilities are expected to propel the market over forecast period. However, stringent regulatory guidelines for the manufacturing and higher manufacturing cost may restrain the growth of sterile injectable contract manufacturing market over the forecast period.

 

Market Scope: Sterile Injectable Contract Manufacturing Market

Global sterile injectable contract manufacturing market is segmented on the basis of product type, service type, drug type, therapeutic area, end user, and region

Based on the product type, the market is segmented into the following:

  • Small Volume Products
  • Large Volume Products
  • Suspensions
  • Lyophilized Products
  • Others

Based on service type, the market is segmented into the following:

  • Formulation
  • Analytical Services
  • Packaging
  • Others

Based on the drug type, the market is segmented into the following:

  • Immunoglobulins
  • Cytokines
  • Monoclonal Antibodies
  • Vaccines
  • Insulin
  • Peptide Hormones
  • Antibiotics
  • Others

Based on the therapeutic area, the market is segmented into the following:

  • Diabetes
  • Cancer
  • Infectious Diseases
  • Neurological Diseases
  • Cardiovascular Diseases
  • Musculoskeletal Diseases
  • Others

Based on the end user, the market is segmented into the following:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Others

Based on region, the market is segmented into the following:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Regional Analysis:  Sterile Injectable Contract Manufacturing Market

Geographically, sterile injectable contract manufacturing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America sterile injectable contract manufacturing market expected to exhibit significant growth owing to increase in the number of pharmaceutical companies minimal manufacturing facilities, rise in demand for injectable products due to rise in prevalence of chronic diseases such as cancer, and rise in number of contract manufacturing organizations are propel the market. Europe sterile injectable contract manufacturing market is driven by increase in the prevalence of chronic diseases, patent expiries of blockbuster drugs, rise in R&D for reformulation of existed drugs are boost the market. Asia Pacific sterile injectable contract manufacturing market expected to present lucrative growth opportunities due to presence of large patient pool, low manufacturing cost in Asia Pacific region, and rise in focus on R&D for the innovation of newer drugs are fuel the market.

 

Competition Assessment: Sterile Injectable Contract Manufacturing Market

Key player profiles in the global sterile injectable contract manufacturing market include:

  • Baxter International, Inc. (U.S.)
  • Bryllon LLC (U.S.)
  • Pfizer CentreOne (Pfizer, Inc.) (U.S.)
  • Aenova Holding GmbH (Germany)
  • Vetter Pharma-Fertigung GmbH & Co. KG (Germany)
  • Catalent Pharma Solutions (Catalent, Inc.) (U.S.)
  • West Pharmaceutical Services, Inc. (U.S.)
  • AbbVie, Inc. (U.S.)
  • Jubilant HollisterStier LLC (Jubilant Life sciences) (India)
  • Recipharm AB (Sweden)

Notable Market Developments: Sterile Injectable Contract Manufacturing Market

  • In February 2017, Pfizer CentreOne expanded its fill-finish services to Michigan site that provides vial filling of small and large molecules and sterile suspensions

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Location

GEOGRAPHY

PBI Location Map

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX